HCAT
Signal
Bullish Setup2
Price
1
Move+1.71%Positive session
Volume
1
Volume1.1× avgNormal activity
Technical
1
RSIRSI 23Oversold — bounce setup
Next earnings: Aug 6, 2026 · After close
ANALYST COVERAGE20 analysts
BUY
+68.1%upside to target
L $1.75
Med $2.00consensus
H $3.00
Buy
1260%
Hold
840%
12 Buy (60%)8 Hold (40%)0 Sell (0%)
Full report →
PRICE
Prev Close
1.17
Open
1.16
Day Range1.14 – 1.23
1.14
1.23
52W Range0.96 – 4.29
0.96
4.29
7% of range
VOLUME & SIZE
Avg Volume
792.4K
FUNDAMENTALS
P/E Ratio
-0.3x
Not profitable
EPS (TTM)
Div Yield
No dividend
Beta
1.64
High vol
Upcoming Events
EEarnings Report
Tomorrow
May 18
DEx-Dividend
In 89 days
Aug 14
PDividend Pay
In 116 days
Sep 10
Key MetricsTTM
Market Cap$87.93M
Revenue TTM$302.48M
Net Income TTM-$265.26M
Free Cash Flow$9.17M
Gross Margin46.0%
Operating Margin-19.2%
Net Margin-87.7%
Return on Equity-99.8%
Return on Assets-64.4%
Debt / Equity0.14
Current Ratio1.69
EPS TTM$-3.65

HCAT News

About

health catalyst is dedicated to enabling health care organizations to fundamentally improve care by building the most comprehensive and fully integrated suite of healthcare data warehousing and process improvement solutions available. health catalyst was formed by a group of healthcare veterans with vast data warehousing and quality improvement experience. our founders and executives collaborated for nearly a decade to revolutionize clinical process models using analytics. during development, they faced numerous hurdles in the quest to develop a data warehouse that could handle the complexities unique to healthcare data. after determining that the predominant approaches to data modeling weren’t effective for healthcare data, they discovered the solution, which is now known as the adaptive data architecture. using a late-binding bus architecture, catalyst’s adaptive data model is agile, flexible, and can be implemented in a matter of weeks compared to the months or years traditional app

Industry
Data Processing, Hosting, and Related Services
Sadiqa MahmoodGM & Senior VP of Life Sciences Business
Holly RimmaschSenior Vice President & Chief Clinical Officer
Kristen BerrySenior Vice President of Public Relations
Benjamin AlbertChief Executive Officer & Director
Benjamin LandryGeneral Counsel & Secretary of the Board
Jason AlgerChief Financial Officer
Jeffrey SelanderSenior Vice President of International
Kyle J. SalyersChief Strategy Officer & Senior Vice President of Corporate Development
Matt HopperSenior Vice President of Finance & Head of Investor Relations
Amanda FlandersSenior Vice President of Marketing & Communications
Carrie KozlowskiChief Marketing Officer
Cathy R. MenkienaSenior VP & GM of Strategic Accounts, North America
Linda LlewelynChief People Officer